Lifeward (LFWD) announced that an Israeli soldier wounded in the current war has completed training and has taken home his own ReWalk Personal Exoskeleton. The soldier, who is paralyzed in both legs, becomes the first Israeli injured in the war to use an exoskeleton to stand and walk again. The 25 year-old reserve combat soldier in the Israel Defense Force Paratroopers Reserve Brigade shared his story and experiences using the ReWalk with Israel Hayom, the most widely distributed daily newspaper in Israel.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LFWD:
- Lifeward launches sales of ReWalk 7 Personal Exoskeleton in the U.S.
- Lifeward Announces Termination of Chief Sales Officer
- Lifeward announces FDA clearance for ReWalk 7 exoskeleton
- Positive Outlook for Lifeward Driven by Strategic Partnerships and Market Expansion Initiatives
- Lifeward price target lowered to $4 from $4.50 at Lake Street
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue